MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 140.9
(0.61%)
EUR 140.9
(0.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.52 Billion EUR | -13.63% |
| 2022 | 6.27 Billion EUR | 13.12% |
| 2021 | 5.88 Billion EUR | 26.07% |
| 2020 | 4.77 Billion EUR | 11.85% |
| 2019 | 4.11 Billion EUR | 13.99% |
| 2018 | 3.46 Billion EUR | -11.33% |
| 2017 | 4.16 Billion EUR | -0.19% |
| 2016 | 4.23 Billion EUR | 15.74% |
| 2015 | 3.62 Billion EUR | 13.54% |
| 2014 | 3.14 Billion EUR | -12.98% |
| 2013 | 3.09 Billion EUR | 11.99% |
| 2012 | 3.27 Billion EUR | 34.64% |
| 2011 | 2.75 Billion EUR | 2.82% |
| 2010 | 2.36 Billion EUR | 40.95% |
| 2009 | 1.64 Billion EUR | -38.94% |
| 2008 | 2.34 Billion EUR | 2.68% |
| 2007 | 1.13 Billion EUR | 124.93% |
| 2006 | 1.1 Billion EUR | 8.24% |
| 2005 | 1.17 Billion EUR | -22.54% |
| 2004 | 1.12 Billion EUR | 13.73% |
| 2003 | 1 Billion EUR | 27.71% |
| 2002 | 920 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.83 Billion EUR | 0.65% |
| 2024 Q1 | 1.52 Billion EUR | 28.62% |
| 2023 Q1 | 1.53 Billion EUR | -6.29% |
| 2023 Q2 | 1.53 Billion EUR | 0.0% |
| 2023 FY | - EUR | -13.63% |
| 2023 Q4 | 1.33 Billion EUR | -9.91% |
| 2023 Q3 | 1.48 Billion EUR | -3.32% |
| 2022 FY | - EUR | 13.12% |
| 2022 Q1 | 1.63 Billion EUR | 10.0% |
| 2022 Q2 | 1.74 Billion EUR | 6.41% |
| 2022 Q4 | 1.63 Billion EUR | -5.26% |
| 2022 Q3 | 1.72 Billion EUR | -0.86% |
| 2021 Q3 | 1.51 Billion EUR | 1.96% |
| 2021 Q4 | 1.49 Billion EUR | -1.46% |
| 2021 FY | - EUR | 26.07% |
| 2021 Q1 | 1.49 Billion EUR | 68.5% |
| 2021 Q2 | 1.48 Billion EUR | -1.0% |
| 2020 FY | - EUR | 11.85% |
| 2020 Q1 | 1.15 Billion EUR | -1.95% |
| 2020 Q2 | 1.06 Billion EUR | -8.15% |
| 2020 Q3 | 1.62 Billion EUR | 53.4% |
| 2020 Q4 | 889 Million EUR | -45.33% |
| 2019 Q4 | 1.17 Billion EUR | 7.19% |
| 2019 Q1 | 873 Million EUR | -18.26% |
| 2019 Q2 | 1.1 Billion EUR | 26.69% |
| 2019 Q3 | 1.09 Billion EUR | -0.72% |
| 2019 FY | - EUR | 13.99% |
| 2018 Q4 | 1.06 Billion EUR | 24.91% |
| 2018 Q2 | 853 Million EUR | -10.49% |
| 2018 Q1 | 953 Million EUR | 19.13% |
| 2018 FY | - EUR | -11.33% |
| 2018 Q3 | 855 Million EUR | 0.23% |
| 2017 Q3 | 1.31 Billion EUR | 30.85% |
| 2017 Q2 | 1 Billion EUR | -16.21% |
| 2017 Q1 | 1.2 Billion EUR | 24.28% |
| 2017 FY | - EUR | -0.19% |
| 2017 Q4 | 800 Million EUR | -39.35% |
| 2016 Q1 | 1.28 Billion EUR | 61.2% |
| 2016 Q4 | 968 Million EUR | -12.79% |
| 2016 Q3 | 1.11 Billion EUR | 3.74% |
| 2016 Q2 | 1.07 Billion EUR | -16.54% |
| 2016 FY | - EUR | 15.74% |
| 2015 Q2 | 845 Million EUR | 4.92% |
| 2015 FY | - EUR | 13.54% |
| 2015 Q4 | 795.3 Million EUR | -11.69% |
| 2015 Q3 | 900.6 Million EUR | 6.58% |
| 2015 Q1 | 805.4 Million EUR | -2.02% |
| 2014 Q4 | 822 Million EUR | 5.18% |
| 2014 FY | - EUR | -12.98% |
| 2014 Q1 | 770.3 Million EUR | 2.31% |
| 2014 Q2 | 767 Million EUR | -0.43% |
| 2014 Q3 | 781.5 Million EUR | 1.89% |
| 2013 Q2 | 791.7 Million EUR | 5.03% |
| 2013 FY | - EUR | 11.99% |
| 2013 Q4 | 752.9 Million EUR | -5.47% |
| 2013 Q3 | 796.5 Million EUR | 0.61% |
| 2013 Q1 | 753.8 Million EUR | 5.0% |
| 2012 FY | - EUR | 34.64% |
| 2012 Q1 | 654 Million EUR | 3.76% |
| 2012 Q2 | 375.1 Million EUR | -42.65% |
| 2012 Q4 | 717.9 Million EUR | 8.62% |
| 2012 Q3 | 660.9 Million EUR | 76.19% |
| 2011 Q2 | 586.5 Million EUR | -33.55% |
| 2011 Q3 | 647.2 Million EUR | 10.35% |
| 2011 Q4 | 630.3 Million EUR | -2.61% |
| 2011 FY | - EUR | 2.82% |
| 2011 Q1 | 882.6 Million EUR | 45.74% |
| 2010 Q4 | 605.6 Million EUR | -7.99% |
| 2010 FY | - EUR | 40.95% |
| 2010 Q3 | 658.2 Million EUR | 17.54% |
| 2010 Q1 | 541.3 Million EUR | 103.19% |
| 2010 Q2 | 560 Million EUR | 3.45% |
| 2009 Q1 | 490.3 Million EUR | 0.0% |
| 2009 Q2 | 404.4 Million EUR | -17.52% |
| 2009 FY | - EUR | -38.94% |
| 2009 Q3 | 447.4 Million EUR | 10.63% |
| 2009 Q4 | 266.4 Million EUR | -40.46% |
| 2008 FY | - EUR | 2.68% |
| 2007 FY | - EUR | 124.93% |
| 2006 FY | - EUR | 8.24% |
| 2005 FY | - EUR | -22.54% |
| 2004 FY | - EUR | 13.73% |
| 2003 FY | - EUR | 27.71% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| MPH Health Care AG | 33.31 Million EUR | -16472.63% |
| Apontis Pharma AG | -12.94 Million EUR | 42761.763% |
| Dermapharm Holding SE | 277.29 Million EUR | -1891.013% |
| Evotec SE | 7.82 Million EUR | -70473.949% |
| PharmaSGP Holding SE | 35.86 Million EUR | -15292.55% |
| SynBiotic SE | -7.12 Million EUR | 77613.84% |